Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Racke

Showing results (11-20 of 225) with videos related to

Pageof 23
Sort By:
JAMA Neurology|June 14, 2016
Cortical Volume Loss and Neurologic Dysfunction in Multiple SclerosisMichael K Racke, Jaime Imitola
JAMA Neurology|February 28, 2017
Selection of Patients With Multiple Sclerosis to Undergo Autologous Hematopoietic Stem Cell TransplantationMichael K Racke, Jaime Imitola
Journal of Neuroimmunology|June 26, 2012
New technologies for biomarker discovery in multiple sclerosisManuel Comabella, Michael K Racke
Therapeutic Advances in Neurological Disorders|December 25, 2010
Natalizumab: Increased Vigilance is Required in Treating Patients with Multiple SclerosisMichael K Racke, Olaf Stüve
JAMA Neurology|March 9, 2016
Will Biomarkers Determine What Is Next in Multiple Sclerosis?: Biomarkers in Multiple SclerosisOlaf Stüve, Michael K Racke
Expert Opinion on Pharmacotherapy|May 26, 2009
Pharmacotherapy of multiple sclerosis: the PROOF trialAaron Boster, Michael K Racke
The Journal of Physiology|August 1, 1993
Protein kinase C modulates hormone secretion regulated by extracellular polycations in bovine parathyroid cellsF K Racke, E F Nemeth
The American Journal of Physiology|September 1, 1994
Stimulus-secretion coupling in parathyroid cells deficient in protein kinase C activityF K Racke, E F Nemeth
PPAR Research|August 7, 2008
PPARs in NeuroinflammationMichael K Racke, Paul D Drew
Expert Review of Neurotherapeutics|March 11, 2009
Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis?Erin E Longbrake, Michael K Racke
Pageof 23

Showing results (11-20 of 225) with videos related to

Sort By:
Pageof 23
JAMA Neurology|June 14, 2016
Cortical Volume Loss and Neurologic Dysfunction in Multiple SclerosisMichael K Racke, Jaime Imitola
JAMA Neurology|February 28, 2017
Selection of Patients With Multiple Sclerosis to Undergo Autologous Hematopoietic Stem Cell TransplantationMichael K Racke, Jaime Imitola
Journal of Neuroimmunology|June 26, 2012
New technologies for biomarker discovery in multiple sclerosisManuel Comabella, Michael K Racke
Therapeutic Advances in Neurological Disorders|December 25, 2010
Natalizumab: Increased Vigilance is Required in Treating Patients with Multiple SclerosisMichael K Racke, Olaf Stüve
JAMA Neurology|March 9, 2016
Will Biomarkers Determine What Is Next in Multiple Sclerosis?: Biomarkers in Multiple SclerosisOlaf Stüve, Michael K Racke
Expert Opinion on Pharmacotherapy|May 26, 2009
Pharmacotherapy of multiple sclerosis: the PROOF trialAaron Boster, Michael K Racke
The Journal of Physiology|August 1, 1993
Protein kinase C modulates hormone secretion regulated by extracellular polycations in bovine parathyroid cellsF K Racke, E F Nemeth
The American Journal of Physiology|September 1, 1994
Stimulus-secretion coupling in parathyroid cells deficient in protein kinase C activityF K Racke, E F Nemeth
PPAR Research|August 7, 2008
PPARs in NeuroinflammationMichael K Racke, Paul D Drew
Expert Review of Neurotherapeutics|March 11, 2009
Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis?Erin E Longbrake, Michael K Racke
Pageof 23